Zydus Lifesciences share price extended the gains on second day, rising 1 percent in the early trade on April 15 following United States Food and Drug Administration (USFDA) approval for Jaythari ...

Expert Rev Cardiovasc Ther. 2012;10(3):387-395. Patients on bedrest will continue to have OH despite other treatment measures. Time out of bed – at least sitting – is preferred. Exercise and ...

At close: April 15 at 3:42:47 p.m. EDT ...